This regulatory report is being submitted as part of a retrospective review and remediation per (b)(4) related to capa pr 564122.Select patient information cannot be included in regulatory report due to regional privacy regulations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
Medtronic received information that 5 years and 9 months post implant of this 23mm aortic bioprosthetic valve, the patient was hospitalized due to delirium and hypercapnia resulting from worsening of chronic obstructive pulmonary disease (copd).The patient received intravenous (iv) fluids due to high creatinine resulting in worsening of breathing status and development of pulmonary edema and congestive heart failure.It was stated that the patients congestive heart failure worsened and they experienced significant kidney disease.10 days after admission, the patient was discharged back to a retirement home for palliative care.2 days following discharge, the patient died.The cause of death was reported as congestive heart failure with significant kidney disease.It is unknown whether an autopsy was performed.
|